Skip to content

Author

Monica Puligheddu

We have 3 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Beyond seizure control: Non-seizure-related outcomes in focal-onset epilepsy treated with adjunctive cenobamate. Third interim results from the BLESS study.

OBJECTIVE Cenobamate is approved for treatment of focal seizures in adults, but evidence on non-seizure outcomes remains limited. This interim statistical analysis of the cenoBamate in aduLts with focal-onsEt SeizureS (BLESS) study evaluated patient- and clinician-reported outcomes for up to 52 weeks of cenobamate trea...

Simona Lattanzi, G. d'Orsi, M. T. Di Claudio et al. · 0 citations
Case report Open access Oct 2026

Ekbom Spectrum Psychosis Associated with 24-hour Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in Parkinson's Disease.

Continuous subcutaneous foslevodopa/foscarbidopa infusion (CSFLI) is an emerging treatment for advanced Parkinson's disease (PD). We report atypical psychosis with Ekbom-like somatic hallucinations during CSFLI. A 74-year-old man with a 16-year history of PD (Hoehn and Yahr stage 3), mild cognitive impairment (Montreal...

Mario Meloni, Fabrizio De Ascaniis, Gianni Orofino et al. · 0 citations
Open access Aug 2026

Cognitive Impairment in isolated REM Sleep Behavior Disorder: a data-driven approach to understanding the heterogeneity of different phenotypes. A pilot study.

Data-driven analyses suggest three distinct cognitive profiles within MCI-RBD, with executive-attentional dysfunction emerging as a prominent feature and potentially representing a key target for cognitive evaluation and risk stratification.

Martina Mulas, F. Meloni, M. Figorilli et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.